Document is current
Any future updates will be listed below
-
Authors
Airagnes, Guillaume https://orcid.org/0000-0002-3494-5083
Sánchez-Rico, Marina
Deguilhem, Amélia https://orcid.org/0000-0003-0619-8401
Blanco, Carlos https://orcid.org/0000-0001-6187-3057
Olfson, Mark
Ouazana Vedrines, Charles https://orcid.org/0000-0002-3587-7182
Lemogne, Cédric https://orcid.org/0000-0002-3487-4721
Limosin, Frédéric https://orcid.org/0000-0002-0976-1514
Hoertel, Nicolas
- License Information
-
More Information
Article History
Received: 19 December 2023
Revised: 2 September 2024
Accepted: 4 September 2024
First Online: 11 September 2024
Competing interests
: GA received speaker and/or consulting fees from Pfizer, Pierre Fabre, Lundbeck, and Zentiva, outside the submitted work. Other authors have no conflict of interest to declare.
: All methods were performed in accordance with the relevant guidelines and regulations. All procedures received full human subjects review and approval from the US Census Bureau and US Office of Management and Budget. All participants provided written informed consent.
